Michael Daly
About Michael Daly
Michael Daly is a retired professional with extensive experience in clinical operations and research, having held leadership roles at Bristol-Myers Squibb, AMRAD, and Zeneca Pharmaceuticals.
Title
Michael Daly holds the position of Hub Unit Director, Regional Clinical Operations. He is also the Director of Clinical Operations, Clinical Sciences & Operations at Bristol-Myers Squibb. Despite his retirement in 2017, he continues to contribute to the pharmaceutical industry.
Current Roles at Bristol-Myers Squibb
Michael Daly is engaged in multiple high-level roles at Bristol-Myers Squibb. He is the Hub Unit Director for Regional Clinical Operations and also serves as the Director of Clinical Operations, Clinical Sciences & Operations. His responsibilities encompass managing and overseeing various clinical research projects within the company.
Retired After a Long Career
Michael Daly retired in March 2017 after an extensive career in clinical operations and research. His professional journey is marked by various significant roles that have contributed to advancements in the pharmaceutical industry. Even after retirement, he remains active in the field, continuing to share his expertise.
Past Positions at AMRAD and Zeneca Pharmaceuticals
Before his tenure at Bristol-Myers Squibb, Michael Daly held leadership roles in other prominent pharmaceutical companies. He was the Head of Clinical Research at AMRAD from 1999 to 2003. Prior to that, he served as the Clinical Research Manager for Australia at Zeneca Pharmaceuticals from 1998 to 1999.
Extensive Experience in Clinical Operations
Michael Daly has over two decades of experience in managing clinical operations and research in the pharmaceutical industry. His roles at companies like AMRAD, Zeneca Pharmaceuticals, and Bristol-Myers Squibb highlight his capabilities in overseeing clinical trials and ensuring compliance with regulatory standards.